Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Barbara Bohle

Showing results (21-30 of 125) with videos related to

Pageof 13
Sort By:
The Journal of Allergy and Clinical Immunology|August 8, 2007
Sublingual immunotherapy induces IL-10-producing T regulatory cells, allergen-specific T-cell tolerance, and immune deviationBarbara Bohle, Tamar Kinaciyan, Marianne Gerstmayr, et al.
The Journal of Allergy and Clinical Immunology|April 8, 2020
IgE-blocking antibodies following SLIT with recombinant Mal d 1 accord with improved apple allergyGabriela Sánchez Acosta, Tamar Kinaciyan, Claudia Kitzmüller, et al.
Allergy|September 23, 2024
Cross-protection of allergen immunotherapy-induced antibodies to related allergens requires a high degree of structural identityHilal Demir, Christian Radauer, Maria R Strobl, et al.
The Journal of Allergy and Clinical Immunology|May 8, 2004
FcepsilonRI engagement of Langerhans cell-like dendritic cells and inflammatory dendritic epidermal cell-like dendritic cells induces chemotactic signals and different T-cell phenotypes in vitroNatalija Novak, Rudolf Valenta, Barbara Bohle, et al.
Clinical and Experimental Allergy : Journal of the British Society for Allergy and Clinical Immunology|January 6, 2024
Easy assessment of the avidity of polyclonal allergen-specific serum antibodiesMaria R Strobl, Hilal Demir, Gordana Wozniak-Knopp, et al.
Heliyon|November 30, 2023
T-cell subset changes during the first year of pre-seasonal allergoid allergen-specific immunotherapyManuel Reithofer, Simone Lisa Boell, Claudia Kitzmueller, et al.
Molecular Immunology|April 21, 2009
Structural and immunological characterization of the N-glycans from the major yellow jacket allergen Ves v 2: the N-glycan structures are needed for the human antibody recognitionUlla Seppälä, David Selby, Rafael Monsalve, et al.
The Journal of Allergy and Clinical Immunology|May 1, 2017
Fusion proteins of flagellin and the major birch pollen allergen Bet v 1 show enhanced immunogenicity, reduced allergenicity, and intrinsic adjuvanticityClaudia Kitzmüller, Julia Kalser, Sonja Mutschlechner, et al.
European Journal of Immunology|November 25, 2003
Bet v 1, the major birch pollen allergen, initiates sensitization to Api g 1, the major allergen in celery: evidence at the T cell levelBarbara Bohle, Astrid Radakovics, Beatrice Jahn-Schmid, et al.
Journal of Immunology (Baltimore, Md. : 1950)|November 8, 2002
The T cell response to Art v 1, the major mugwort pollen allergen, is dominated by one epitopeBeatrice Jahn-Schmid, Peter Kelemen, Martin Himly, et al.
Pageof 13

Showing results (21-30 of 125) with videos related to

Sort By:
Pageof 13
The Journal of Allergy and Clinical Immunology|August 8, 2007
Sublingual immunotherapy induces IL-10-producing T regulatory cells, allergen-specific T-cell tolerance, and immune deviationBarbara Bohle, Tamar Kinaciyan, Marianne Gerstmayr, et al.
The Journal of Allergy and Clinical Immunology|April 8, 2020
IgE-blocking antibodies following SLIT with recombinant Mal d 1 accord with improved apple allergyGabriela Sánchez Acosta, Tamar Kinaciyan, Claudia Kitzmüller, et al.
Allergy|September 23, 2024
Cross-protection of allergen immunotherapy-induced antibodies to related allergens requires a high degree of structural identityHilal Demir, Christian Radauer, Maria R Strobl, et al.
The Journal of Allergy and Clinical Immunology|May 8, 2004
FcepsilonRI engagement of Langerhans cell-like dendritic cells and inflammatory dendritic epidermal cell-like dendritic cells induces chemotactic signals and different T-cell phenotypes in vitroNatalija Novak, Rudolf Valenta, Barbara Bohle, et al.
Clinical and Experimental Allergy : Journal of the British Society for Allergy and Clinical Immunology|January 6, 2024
Easy assessment of the avidity of polyclonal allergen-specific serum antibodiesMaria R Strobl, Hilal Demir, Gordana Wozniak-Knopp, et al.
Heliyon|November 30, 2023
T-cell subset changes during the first year of pre-seasonal allergoid allergen-specific immunotherapyManuel Reithofer, Simone Lisa Boell, Claudia Kitzmueller, et al.
Molecular Immunology|April 21, 2009
Structural and immunological characterization of the N-glycans from the major yellow jacket allergen Ves v 2: the N-glycan structures are needed for the human antibody recognitionUlla Seppälä, David Selby, Rafael Monsalve, et al.
The Journal of Allergy and Clinical Immunology|May 1, 2017
Fusion proteins of flagellin and the major birch pollen allergen Bet v 1 show enhanced immunogenicity, reduced allergenicity, and intrinsic adjuvanticityClaudia Kitzmüller, Julia Kalser, Sonja Mutschlechner, et al.
European Journal of Immunology|November 25, 2003
Bet v 1, the major birch pollen allergen, initiates sensitization to Api g 1, the major allergen in celery: evidence at the T cell levelBarbara Bohle, Astrid Radakovics, Beatrice Jahn-Schmid, et al.
Journal of Immunology (Baltimore, Md. : 1950)|November 8, 2002
The T cell response to Art v 1, the major mugwort pollen allergen, is dominated by one epitopeBeatrice Jahn-Schmid, Peter Kelemen, Martin Himly, et al.
Pageof 13